公开(公告)号：US20220259235A1

公开(公告)日：2022-08-18

申请号：US17629976

申请日：2020-07-23

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Xiangyong Liu ,  Changyong Qiu ,  Qichao Shen ,  Mengqiang Liu ,  Haitong Sheng ,  Xiaodong Song ,  Guolong Du ,  Jiabing Wang ,  Lieming Ding

IPC: C07F9/6558 ,  A61P35/00 ,  C07F9/6561

Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as EGFR inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.